Fig. 3: Time to next treatment (TTNT) and overall survival (OS) from first relapse estimates in 1439 treated patients with multiple myeloma stratified by the year of initiation of second-line therapy.
From: Second- and third-line treatment strategies in multiple myeloma: a referral-center experience
CI confidence interval.
